HER2-positive Bladder Cancer
3 clinical trials · Condition
◉ Watch HER2-positive Bladder Cancer
| Record | Firm | Date |
|---|---|---|
| PRS-343 in HER2-Positive Solid Tumors (NCT03330561) | Pieris Pharmaceuticals, Inc. | 2017-09-13 |
Track HER2-positive Bladder Cancer automatically
Every clearance here is in the API, with alerts when new ones post.